BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11861872)

  • 1. CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68.
    Lee BJ; Reiter SK; Anderson M; Sarawar SR
    J Virol; 2002 Mar; 76(6):3049-53. PubMed ID: 11861872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68.
    Lyon AB; Sarawar SR
    Virology; 2006 Dec 5-20; 356(1-2):50-6. PubMed ID: 16934307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis.
    Lee BJ; Santee S; Von Gesjen S; Ware CF; Sarawar SR
    J Virol; 2000 Mar; 74(6):2786-92. PubMed ID: 10684295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and costimulatory molecules in the immune response to murine gammaherpesvirus-68.
    Sarawar SR; Lee BJ; Giannoni F
    Viral Immunol; 2004; 17(1):3-11. PubMed ID: 15018658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
    Fuse S; Zhang W; Usherwood EJ
    J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated control of persistent gamma-herpesvirus infection.
    Kim IJ; Flaño E; Woodland DL; Blackman MA
    J Immunol; 2002 Apr; 168(8):3958-64. PubMed ID: 11937552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity.
    Welten SPM; Redeker A; Toes REM; Arens R
    J Virol; 2016 May; 90(9):4402-4411. PubMed ID: 26889035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon.
    Aricò E; Robertson K; Allen D; Ferrantini M; Belardelli F; Nash AA
    J Interferon Cytokine Res; 2002 Nov; 22(11):1081-8. PubMed ID: 12513907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.
    Usherwood EJ; Stewart JP; Robertson K; Allen DJ; Nash AA
    J Gen Virol; 1996 Nov; 77 ( Pt 11)():2819-25. PubMed ID: 8922476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant.
    Boname JM; Coleman HM; May JS; Stevenson PG
    J Gen Virol; 2004 Jan; 85(Pt 1):131-135. PubMed ID: 14718627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C theta is not essential for T-cell-mediated clearance of murine gammaherpesvirus 68.
    Giannoni F; Lyon AB; Wareing MD; Dias PB; Sarawar SR
    J Virol; 2005 Jun; 79(11):6808-13. PubMed ID: 15890920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus.
    Weinberg JB; Lutzke ML; Alfinito R; Rochford R
    Viral Immunol; 2004; 17(1):69-77. PubMed ID: 15018663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
    El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
    Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into CD8 T Cell Activation and Exhaustion from a Mouse Gammaherpesvirus Model.
    Sarawar SR; Shen J; Dias P
    Viral Immunol; 2020 Apr; 33(3):215-224. PubMed ID: 32286179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion and activation of NK cell populations in a gammaherpesvirus infection.
    Thomson RC; Petrik J; Nash AA; Dutia BM
    Scand J Immunol; 2008 May; 67(5):489-95. PubMed ID: 18363592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells.
    Usherwood EJ; Ross AJ; Allen DJ; Nash AA
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():627-30. PubMed ID: 8627250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of murine gammaherpesvirus infection is independent of NK cells.
    Usherwood EJ; Meadows SK; Crist SG; Bellfy SC; Sentman CL
    Eur J Immunol; 2005 Oct; 35(10):2956-61. PubMed ID: 16134085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
    Coppola MA; Flaño E; Nguyen P; Hardy CL; Cardin RD; Shastri N; Woodland DL; Blackman MA
    J Immunol; 1999 Aug; 163(3):1481-9. PubMed ID: 10415050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic study of atypical lymphocytes. Generated in peripheral blood and spleen of nude mice After MHV-72 infection.
    Raslova H; Mistrikova J; Kudelova M; Mishal Z; Sarasin A; Blangy D; Berebbi M
    Viral Immunol; 2000; 13(3):313-27. PubMed ID: 11016596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.